- Home
- GATX vs GRFS Comparison
GATX vs GRFS Comparison
Compare GATX & GRFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GATX
- GRFS
- Stock Information
- Founded
- GATX 1898
- GRFS 1940
- Country
- GATX United States
- GRFS Spain
- Employees
- GATX N/A
- GRFS 23737
- Industry
- GATX Transportation Services
- GRFS Biotechnology: Pharmaceutical Preparations
- Sector
- GATX Consumer Discretionary
- GRFS Health Care
- Exchange
- GATX Nasdaq
- GRFS Nasdaq
- Market Cap
- GATX 5.8B
- GRFS 5.5B
- IPO Year
- GATX N/A
- GRFS 2006
- Fundamental
- Price
- GATX $161.16
- GRFS $8.05
- Analyst Decision
- GATX Buy
- GRFS Sell
- Analyst Count
- GATX 3
- GRFS 2
- Target Price
- GATX $155.00
- GRFS $10.50
- AVG Volume (30 Days)
- GATX 185.4K
- GRFS 1.3M
- Earning Date
- GATX 01-21-2025
- GRFS 01-01-0001
- Dividend Yield
- GATX 1.44%
- GRFS N/A
- EPS Growth
- GATX 12.61
- GRFS N/A
- EPS
- GATX 7.50
- GRFS 0.27
- Revenue
- GATX $1,540,700,000.00
- GRFS $7,814,096,584.00
- Revenue This Year
- GATX $14.32
- GRFS $8.86
- Revenue Next Year
- GATX $7.75
- GRFS $7.00
- P/E Ratio
- GATX $21.48
- GRFS $35.12
- Revenue Growth
- GATX 12.88
- GRFS 7.21
- 52 Week Low
- GATX $114.78
- GRFS $5.30
- 52 Week High
- GATX $167.74
- GRFS $12.15
- Technical
- Relative Strength Index (RSI)
- GATX 56.97
- GRFS 51.40
- Support Level
- GATX $159.84
- GRFS $7.29
- Resistance Level
- GATX $167.74
- GRFS $7.85
- Average True Range (ATR)
- GATX 3.12
- GRFS 0.33
- MACD
- GATX -0.92
- GRFS 0.06
- Stochastic Oscillator
- GATX 30.52
- GRFS 77.22
About GATX GATX Corporation
GATX Corp is a provider of railcar leasing and maintenance services. GATX operates four business segments: rail North America, rail international, and portfolio management. The rail business offers railcar leasing and maintenance, as well as asset-related, financial, and management services. The company owns and leases fleets in North America, Europe, and Asia, which consist of tank and freight railcars. Industries served include refining and petroleum, chemicals and plastics, railroads and other transportation, mining, and food and agriculture.
About GRFS Grifols S.A.
As a vertically integrated plasma derivative producer, Spain-based Grifols collects plasma and then manufactures and sells plasma-derived products globally. By acquiring Talecris in 2011, Grifols dramatically expanded its plasma-derived product portfolio, and following the firm's Biotest acquisition in April 2022, the biopharma business contributed 84% of sales in 2023. Grifols also has smaller segments including diagnostics (10% of sales) and biosupplies.